Autophagy and endocrine resistance in breast cancer

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J. Clin.60(5), 277–300 (2010).
   PubMed Web of Science ®Google Scholar
• Jemal A, Center MM, Ward E et al. Cancer occurrence. Methods Mol. Biol.471, 3–29 (2009).
   PubMedGoogle Scholar
• Parkin DM, Fernandez LM. Use of statistics to assess the global burden of breast cancer. Breast J.12(Suppl. 1), S70–S80 (2006).
   PubMed Web of Science ®Google Scholar
• Clarke M, Collins R, Davies C et al. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet351(9114), 1451–1467 (1998).
   PubMed Web of Science ®Google Scholar
• Doggrell SA. Is long-term adjuvant treatment of breast cancer with anastrozole indicated? Expert. Opin. Pharmacother.9(9), 1619–1622 (2008).
   PubMed Web of Science ®Google Scholar
• Howell A. Pure oestrogen antagonists for the treatment of advanced breast cancer. Endocr. Relat. Cancer13(3), 689–706 (2006).
   PubMed Web of Science ®Google Scholar
• Howell A. Fulvestrant (‘Faslodex’): current and future role in breast cancer management. Crit. Rev. Oncol. Hematol.57(3), 265–273 (2006).
   Google Scholar
• Robertson JF. Fulvestrant (Faslodex) – how to make a good drug better. Oncologist12(7), 774–784 (2007).
   PubMed Web of Science ®Google Scholar
• No authors listed. Highlights from the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) 2005–2006 worldwide overview. Breast Cancer Res. Treat.100, S19 (2006).
   Google Scholar
• Abe O, Abe R, Enomoto K et al. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet352(9132), 930–942 (1998).
   Google Scholar
• Clarke R, Skaar TC, Bouker KB et al. Molecular and pharmacological aspects of antiestrogen resistance. J. Steroid Biochem. Mol. Biol.76(1–5), 71–84 (2001).
   PubMed Web of Science ®Google Scholar
• Gutierrez MC, Detre S, Johnston S et al. Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor HER-2, and p38 mitogen-activated protein kinase. J. Clin. Oncol.23(11), 2469–2476 (2005).
   PubMed Web of Science ®Google Scholar
• Musgrove EA, Sutherland RL. Biological determinants of endocrine resistance in breast cancer. Nat. Rev. Cancer9(9), 631–643 (2009).
   PubMed Web of Science ®Google Scholar
• Clarke R, Leonessa F, Welch JN et al. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharm. Rev.53(1), 25–71 (2001).
   PubMed Web of Science ®Google Scholar
• Clarke R, Shajahan AN, Wang Y et al. Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer. Hormone Mol. Biol. Clin. Invest.5(1), 35–44 (2011).
   Google Scholar
• Clarke R, Shajahan AN, Riggins RB et al. Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells. J. Steroid Biochem. Mol. Biol.114(1–2), 8–20 (2009).
   PubMed Web of Science ®Google Scholar
• He CC, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Ann. Rev. Genet.43, 67–93 (2009).
   PubMed Web of Science ®Google Scholar
• Pursiheimo JP, Rantanen K, Heikkinen PT et al. Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene28(3), 334–344 (2009).
   PubMed Web of Science ®Google Scholar
• Suzuki K, Kubota Y, Sekito T et al. Hierarchy of Atg proteins in pre-autophagosomal structure organization. Genes Cells12(2), 209–218 (2007).
   PubMed Web of Science ®Google Scholar
• Hara T, Takamura A, Kishi C et al. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J. Cell Biol.181(3), 497–510 (2008).
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH et al. ULK–Atg13–FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell20(7), 1992–2003 (2009).
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T et al. Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy. Mol. Biol. Cell20(7), 1981–1991 (2009).
   PubMed Web of Science ®Google Scholar
• Bjorkoy G, Lamark T, Brech A et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol.171(4), 603–614 (2005).
   PubMed Web of Science ®Google Scholar
• Bjorkoy G, Lamark T, Pankiv S et al. Monitoring autophagic degradation of P62/Sqstm1. Methods Enzymol. Autophagy Mammalian Syst.452, 181–197 (2009).
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem.282(33), 24131–24145 (2007).
   PubMed Web of Science ®Google Scholar
• Criollo A, Maiuri MC, Tasdemir E et al. Regulation of autophagy by the inositol trisphosphate receptor. Cell Death Differentiation14(5), 1029–1039 (2007).
   PubMed Web of Science ®Google Scholar
• Kihara A, Noda T, Ishihara N et al. Two distinct Vps34 phosphatidylinositol 3–kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J. Cell Biol.152(3), 519–530 (2001).
   PubMed Web of Science ®Google Scholar
• Sun Y, Peng ZL. Autophagy, beclin 1, and their relation to oncogenesis. Labmedicine39(5), 287–290 (2008).
   Google Scholar
• Chang CY, Huang WP. Atg19 mediates a dual interaction cargo sorting mechanism in selective autophagy. Mol. Biol. Cell18(3), 919–929 (2007).
   PubMed Web of Science ®Google Scholar
• He CC, Baba M, Klionsky DJ. Double duty of Atg9 self-association in autophagosome biogenesis. Autophagy5(3), 385–387 (2009).
   PubMed Web of Science ®Google Scholar
• Legakis JE, Yen WL, He CC et al. Autophagosome formation involves cycling of ATG9. Autophagy2(4), 334 (2006).
   Web of Science ®Google Scholar
• Legakis JE, Yen WL, Klionsky DJ. A cycling protein complex required for selective autophagy. Autophagy3(5), 422–432 (2007).
   PubMed Web of Science ®Google Scholar
• Yen WL, Legakis JE, Nair U et al. Atg27 is required for autophagy-dependent cycling of Atg9. Mol. Biol. Cell18(2), 581–593 (2007).
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abeliovich H, Agostinis P et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy4(2), 151–175 (2008).
   PubMed Web of Science ®Google Scholar
• Jager S, Bucci C, Tanida I et al. Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci.117(20), 4837–4848 (2004).
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Guhde G, Suter A et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature406(6798), 902–906 (2000).
   PubMed Web of Science ®Google Scholar
• Uchiyama Y. Autophagic cell death and its execution by lysosomal cathepsins. Arch. Histol. Cytol.64(3), 233–246 (2001).
   PubMed Web of Science ®Google Scholar
• Kitada S, Takayama S, De Riel K et al. Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Res. Dev.4(2), 71–79 (1994).
   PubMedGoogle Scholar
• Reed JC, Kitada S, Takayama S et al. Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin’s lymphoma and lymphocytic leukemia cell lines. Ann. Oncol.5(Suppl. 1), 61–65 (1994).
   PubMed Web of Science ®Google Scholar
• Won KY, Kim GY, Kim YW et al. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum. Pathol.41(1), 107–112 (2010).
   PubMed Web of Science ®Google Scholar
• Erlich S, Mizrachy L, Segev O et al. Differential interactions between Beclin 1 and bcl-2 family members. Autophagy3(6), 561–568 (2007).
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Le Toumelin G, Criollo A et al. Functional and physical interaction between Bcl-X-L and a BH3-like domain in Beclin-1. Embo J.26(10), 2527–2539 (2007).
   PubMed Web of Science ®Google Scholar
• Pattingre S, Tassa A, Qu XP et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell122(6), 927–939 (2005).
   PubMed Web of Science ®Google Scholar
• Abedin MJ, Wang D, McDonnell MA et al. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differentiation14(3), 500–510 (2007).
   PubMed Web of Science ®Google Scholar
• Morselli E, Galluzzi L, Kepp O et al. Anti- and pro-tumor functions of autophagy. Biochim. Biophys. Acta Mol. Cell Res.1793(9), 1524–1532 (2009).
   PubMed Web of Science ®Google Scholar
• Elgendy M, Sheridan C, Brumatti G et al. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol. Cell42(1), 23–35 (2011).
   PubMed Web of Science ®Google Scholar
• Germain M, Nguyen AP, Le Grand JN et al. MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner. Embo J.30(2), 395–407 (2011).
   PubMed Web of Science ®Google Scholar
• O’Brien SM, Claxton DF, Crump M et al. Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia. Blood113(2), 299–305 (2009).
   PubMed Web of Science ®Google Scholar
• Akar U, Chaves-Reyez A, Barria M et al. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy4(5), 669–679 (2008).
   PubMed Web of Science ®Google Scholar
• Gao P, Bauvy C, Souquere S et al. The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells. J. Biol. Chem.285(33), 25570–25581 (2010).
   PubMed Web of Science ®Google Scholar
• Shajahan AN, Riggins RB, Clarke R. The role of X-box binding protein-1 in tumorigenicity. Drug News Perspect.22(5), 241–246 (2009).
   Google Scholar
• Gomez BP, Riggins RB, Shajahan AN et al. Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J.21(14), 4013–4027 (2007).
   Google Scholar
• Davies MP, Barraclough DL, Stewart C et al. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer. Int. J. Cancer.123(1), 85–88 (2008).
   Google Scholar
• Ogata M, Hino S, Saito A et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell Biol.26(24), 9220–9231 (2006).
   PubMed Web of Science ®Google Scholar
• Wei YJ, Pattingre S, Sinha S et al. JNK1-mediated phosphorylation of BcI-2 regulates starvation-induced autophagy. Mol. Cell30(6), 678–688 (2008).
   PubMed Web of Science ®Google Scholar
• Brech A, Ahlquist T, Lothe RA et al. Autophagy in tumour suppression and promotion. Mol. Oncol.3(4), 366–375 (2009).
   PubMedGoogle Scholar
• Chen N, Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim. Biophys. Acta Mol. Cell Res.1793(9), 1516–1523 (2009).
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature402(6762), 672–676 (1999).
   PubMed Web of Science ®Google Scholar
• White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin. Cancer Res.15(17), 5308–5316 (2009).
   PubMed Web of Science ®Google Scholar
• Degenhardt K, Mathew R, Beaudoin B et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell10(1), 51–64 (2006).
   PubMed Web of Science ®Google Scholar
• Karantza-Wadsworth V, White E. Role of autophagy in breast cancer. Autophagy3(6), 610–613 (2007).
   PubMed Web of Science ®Google Scholar
• Eisenberg-Lerner A, Bialik S, Simon HU et al. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differentiation16(7), 966–975 (2009).
   PubMed Web of Science ®Google Scholar
• Qu XP, Yu J, Bhagat G et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest.112(12), 1809–1820 (2003).
   PubMed Web of Science ®Google Scholar
• Yue ZY, Jin SK, Yang CW et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl Acad. Sci. USA100(25), 15077–15082 (2003).
   PubMed Web of Science ®Google Scholar
• Miracco C, Cosci E, Oliveri G et al. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int. J. Oncol.30(2), 429–436 (2007).
   PubMed Web of Science ®Google Scholar
• Liang C, Feng P, Ku B et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol.8(7), 688–694 (2006).
   PubMed Web of Science ®Google Scholar
• Marino G, Salvador-Montoliu N, Fueyo A et al. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/Autophagin-3. J. Biol. Chem.282(25), 18573–18583 (2007).
   PubMed Web of Science ®Google Scholar
• Vousden KH, Lane DP. p53 in health and disease. Nat. Rev. Mol. Cell Biol.8(4), 275–283 (2007).
   PubMed Web of Science ®Google Scholar
• Crighton D, Wilkinson S, Ryan KM. DRAM links autophagy to p53 and programmed cell death. Autophagy3(1), 72–74 (2007).
   PubMed Web of Science ®Google Scholar
• Harrison B, Kraus M, Burch L et al. DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing. J. Biol. Chem.283(15), 9999–10014 (2008).
   Google Scholar
• Wang QJ, Ding Y, Kohtz DS et al. Induction of autophagy in axonal dystrophy and degeneration. J. Neurosci.26(31), 8057–8068 (2006).
   PubMed Web of Science ®Google Scholar
• Lemasters JJ, Nieminen AL, Qian T et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta1366(1–2), 177–196 (1998).
   PubMed Web of Science ®Google Scholar
• Tasdemir E, Maiuri MC, Galluzzi L et al. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol.10(6), 676–687 (2008).
   PubMed Web of Science ®Google Scholar
• Reef S, Zalckvar E, Shifman O et al. A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol. Cell22(4), 463–475 (2006).
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis30(7), 1073–1081 (2009).
   PubMed Web of Science ®Google Scholar
• White E. Role of autophagy in cancer and therapy. EJC Suppl.6(12), 16 (2008).
   Google Scholar
• Mathew R, Kongara S, Beaudoin B et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev.21(11), 1367–1381 (2007).
   PubMed Web of Science ®Google Scholar
• Karantza-Wadsworth V, Patel S, Kravchuk O et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev.21(13), 1621–1635 (2007).
   PubMed Web of Science ®Google Scholar
• Sivridis E, Koukourakis MI, Zois CE et al. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am. J. Pathol.176(5), 2477–2489 (2010).
   PubMed Web of Science ®Google Scholar
• Negri T, Tarantino E, Orsenigo M et al. Chromosome band 17q21 in breast cancer: significant association between beclin 1 loss and HER2/NEU amplification. Genes Chromosomes Cancer49(10), 901–909 (2010).
   PubMed Web of Science ®Google Scholar
• Vazquez-Martin A, Cufi S, Oliveras-Ferraros C et al. Expression status of the autophagy-regulatory gene ATG6/BECN1 in ERBB2-positive breast carcinomas: bypassing ERBB2-induced oncogenic senescence to regulate the efficacy of ERBB2-targeted therapies. Genes Chromosomes Cancer50(4), 284–290 (2011).
   Google Scholar
• Tu YF, Kaipparettu BA, Ma Y et al. Mitochondria of highly metastatic breast cancer cell line MDA-MB-231 exhibits increased autophagic properties. Biochim. Biophys. Acta DOI: 10.1016/j.bbabio.2011.04.015 (2011) (Epub ahead of print).
   Google Scholar
• Vanderlaag K, Su Y, Frankel AE et al. 1, 1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes induce autophagic cell death in estrogen receptor negative breast cancer. BMC Cancer10, 669 (2010).
   Google Scholar
• Zhou J, Zhang W, Liang B et al. PPARgamma activation induces autophagy in breast cancer cells. Int. J. Biochem. Cell Biol.41(11), 2334–2342 (2009).
   PubMedGoogle Scholar
• Sinha S, Roy S, Reddy BS et al. A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis. Mol. Cancer Res.9(3), 364–374 (2011).
   PubMed Web of Science ®Google Scholar
• Chen S, Rehman S, Zhang W et al. Autophagy is a therapeutic target in anticancer drug resistance. Biochim. Biophys. Acta1806, 220–229 (2010).
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kanzawa T, Sawaya R et al. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer5(9), 726–734 (2005).
   PubMed Web of Science ®Google Scholar
• Turcotte S, Giaccia AJ. Targeting cancer cells through autophagy for anticancer therapy. Current Opin. Cell Biol.22(2), 246–251 (2010).
   PubMed Web of Science ®Google Scholar
• Crawford AC, Riggins RB, Shajahan AN et al. Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis. Plos One5(1), e8604 (2010).
   Google Scholar
• Ito H, Daido S, Kanzawa T et al. Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int. J. Oncol.26(5), 1401–1410 (2005).
   PubMed Web of Science ®Google Scholar
• Sun WL, Chen J, Wang YP et al. Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy7(10), 1033–1042 (2011).
   Google Scholar
• Milani M, Rzymski T, Mellor HR et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with bortezomib. Cancer Res.69(10), 4415–4423 (2009).
   PubMed Web of Science ®Google Scholar
• Chen S, Li X, Feng J et al. Autophagy facilitates the lapatinib resistance of HER2 positive breast cancer cells. Med. Hypotheses.77(2), 206–208 (2011).
   PubMed Web of Science ®Google Scholar
• Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. Plos One4(7), e6251 (2009).
   PubMed Web of Science ®Google Scholar
• Bursch W, Ellinger A, Kienzl H et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis17(8), 1595–1607 (1996).
   PubMed Web of Science ®Google Scholar
• Samaddar JS, Gaddy VT, Duplantier J et al. A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Mol. Cancer Ther.7(9), 2977–2987 (2008).
   PubMed Web of Science ®Google Scholar
• Qadir MA, Kwok B, Dragowska WH et al. Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res. Treat.112(3), 389–403 (2008).
   PubMed Web of Science ®Google Scholar
• John S, Nayvelt I, Hsu HC et al. Regulation of estrogenic effects by Beclin 1 in breast cancer cells. Cancer Res.68(19), 7855–7863 (2008).
   PubMed Web of Science ®Google Scholar
• Periyasamy-Thandavan S, Jackson WH, Samaddar JS et al. Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells. Autophagy6(1), 19–35 (2010).
   PubMed Web of Science ®Google Scholar
• Thomas S, Thurn KT, Bicaku E et al. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy. Breast Cancer Res. Treat. DOI: 10.1007/s10549-011-1364-y (2011) (Epub ahead of print).
   Google Scholar
• Shu CW, Madiraju C, Zhai D et al. High-throughput fluorescence assay for small-molecule inhibitors of autophagins/Atg4. J. Biomol. Screen.16(2), 174–182 (2011).
   PubMedGoogle Scholar
• Zhang L, Yu J, Pan H et al. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc. Natl Acad. Sci. USA104(48), 19023–19028 (2007).
   PubMed Web of Science ®Google Scholar